dr. nowakowski on next steps with emerging agents in mcl
Published 7 years ago • 233 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:19
dr. nowakowski on the potential role of immunotherapy in mcl
-
1:00
dr. nowakowski on using patient performance score and age for mcl treatment
-
0:58
dr. nowakowski on biological heterogeneity in newly diagnosed patients with mcl
-
0:50
dr. nowakowski on evolving treatment paradigm of mcl
-
0:59
dr. nowakowski on the rationale of the engine trial in dlbcl
-
1:21
dr. goy on approved agents in the treatment landscape of mcl
-
19:58
new agents for mantle cell lymphoma
-
1:25
dr. nowakowski on the rationale for reevaluating enzastaurin in dlbcl
-
23:10
what’s new in mantle cell lymphoma: updates from asco 2024 & the eha hybrid congress
-
1:14:44
taking the leap with innovative strategies in mcl
-
50:04
mantle cell lymphoma: from current treatments to future innovations(podcast)
-
0:43
dr. wang discusses next steps with acalabrutinib in mcl
-
1:18
dr. wang discusses new agents in the field of mcl
-
1:58
dr. wang on car t-cell therapy resistance in mcl
-
1:48
dr. fred hirsch on next steps for necitumumab in nsclc
-
1:42
dr. jain on next steps for venetoclax in relapsed mcl
-
1:18
dr. phillips on emerging combination in mcl
-
0:48
dr. martin on the role of transplant in mantle cell lymphoma
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
1:24
dr. michael williams on lenalidomide plus rituximab in first line mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
0:55
dr. wang on the evolution of treatment in mcl